1. Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4
   Aamir Ahmad et al, 2015, BMC Cancer CrossRef
2. Phosphatidylinositol 3‐Kinase–DNA Methyltransferase 1–miR‐1281–Histone Deacetylase 4 Regulatory Axis Mediates Platelet‐Derived Growth Factor–Induced Proliferation and Migration of Pulmonary Artery Smooth Muscle Cells
   Yanjiao Li et al, 2018, Journal of the American Heart Association CrossRef
3. Apigenin and its combination with Vorinostat induces apoptotic-mediated cell death in TNBC by modulating the epigenetic and apoptotic regulators and related miRNAs
   Snehal Nimal et al, 2024, Scientific Reports CrossRef
4. The emerging roles of HDACs and their therapeutic implications in cancer
   Rihan Hai et al, 2022, European Journal of Pharmacology CrossRef
5. Epigenetic Regulation Towards Acquired Drug Resistance in Cancer
   Madhura Ketkar et al, 2022, Metabolism and Epigenetic Regulation: Implications in Cancer CrossRef
6. Chromosome segregation and organization are targets of 5′-Fluorouracil in eukaryotic cells
   Laura Mojardín et al, 2015, Cell Cycle CrossRef
7. 5-Fluorouracil: A Narrative Review on the Role of Regulatory Mechanisms in Driving Resistance to This Chemotherapeutic Agent
   Soudeh Ghafouri-Fard et al, 2021, Frontiers in Oncology CrossRef
8. SMAD4 contributes to chondrocyte and osteocyte development
   Katayoon Pakravan et al, 2022, Journal of Cellular and Molecular Medicine CrossRef
9. Kinome-Wide siRNA Screening Identifies Src-Enhanced Resistance of Chemotherapeutic Drugs in Triple-Negative Breast Cancer Cells
   Yen-Dun Tony Tzeng et al, 2018, Frontiers in Pharmacology CrossRef
10. Strong Correlation between the Expression Levels of HDAC4 and SIRT6 in Hematological Malignancies of the Adults
    Zsuzsanna Gaál et al, 2017, Pathology & Oncology Research CrossRef
11. Targeting Histone Deacetylases in Diseases: Where Are We?
    Rosaria Benedetti et al, 2015, Antioxidants & Redox Signaling CrossRef
12. Multi-CpG linear regression models to accurately predict paclitaxel and docetaxel activity in cancer cell lines
    Manny D. Bacolod et al, 2023, Epigenetic Regulation of Cancer in Response to Chemotherapy CrossRef
13. Notch and Wnt signaling pathway in cancer: Crucial role and potential therapeutic targets (Review)
    YU-FENG XIAO et al, 2016, International Journal of Oncology CrossRef
14. Synergistic Effect of Cold Atmospheric Plasma and Drug Loaded Core-shell Nanoparticles on Inhibiting Breast Cancer Cell Growth
    Wei Zhu et al, 2016, Scientific Reports CrossRef
15. Smad4 loss promotes lung cancer formation but increases sensitivity to DNA topoisomerase inhibitors
    S M Haeger et al, 2016, Oncogene CrossRef
16. The Impact of Post-Translational Regulation of Histone on Cancer Metastasis and Cancer Chemoresistance
    Lin Liu et al, 2017, Current Pharmacology Reports CrossRef
17. Candidate Oligo Therapeutic Target, miR-330-3p, Induces Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer Cells via HDAC4
    Meng Zhang et al, 2023, The Breast Journal CrossRef
18. Increased EGFR expression induced by a novel oncogene, CUG2, confers resistance to doxorubicin through Stat1-HDAC4 signaling
    Sirichat Kaowinn et al, 2017, Cellular Oncology CrossRef
19. Reduced Smad4 expression and DNA topoisomerase inhibitor chemosensitivity in non-small cell lung cancer
    Michael Ziemke et al, 2017, Lung Cancer CrossRef
20. Targeting post-translational histone modifying enzymes in glioblastoma
    Elena Kunadis et al, 2021, Pharmacology & Therapeutics CrossRef
21. The hopeful anticancer role of oleuropein in breast cancer through histone deacetylase modulation
    Neda Mansouri et al, 2019, Journal of Cellular Biochemistry CrossRef
22. Chromatin factors: Ready to roll as biomarkers in metastatic colorectal cancer?
    Cristina Moreta-Moraleda et al, 2023, Pharmacological Research CrossRef
23. Down-Regulation of MicroRNA-210 Confers Sensitivity towards 1’S-1’-Acetoxychavicol Acetate (ACA) in Cervical Cancer Cells by Targeting SMAD4
    Neoh Hun Phuah et al, 2017, Molecules and Cells CrossRef
24. Structure-Based Identification of Novel Histone Deacetylase 4 (HDAC4) Inhibitors
    Rupesh Agarwal et al, 2024, Pharmaceuticals CrossRef
25. Smad4 re-expression increases the sensitivity to parthenolide in colorectal cancer
    Xuemei Li et al, 2017, Oncology Reports CrossRef
26. HRD1 sensitizes breast cancer cells to Tamoxifen by promoting S100A8 degradation
    YanYang Wang et al, 2017, Oncotarget CrossRef
27. Soft drug inhibitors for the epigenetic targets lysine‐specific demethylase 1 and histone deacetylases
    Johannes Seitz et al, 2024, Archiv der Pharmazie CrossRef
28. Identifying network biomarkers based on protein-protein interactions and expression data
    Jingxue Xin et al, 2015, BMC Medical Genomics CrossRef